Prudential Financial
PRAX icon

Prudential Financial’s Praxis Precision Medicines PRAX Stock Holding History

Prudential Financial’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.54M Sell
19,541
-10,969
-36% -$3.47M 0.01% 873
2026
Q1 		$9.83M Buy
30,510
+15,648
+105% +$4.84M 0.01% 635
2025
Q4 		$4.38M Buy
+14,862
New +$2.77M 0.01% 977
2023
Q4 		– Sell
-1,113
Closed -$28.6K – 2701
2023
Q3 		$28.6K Buy
+1,113
New +$21.1K ﹤0.01% 2552

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Prudential Financial's PRAX Position: Q2 2026 in Review

Prudential Financial reduced its Praxis Precision Medicines (PRAX) stake by 36% in Q2 2026, selling an estimated $3.47M and leaving 19,541 shares worth $6.54M. The position accounts for 0.01% of the portfolio, ranked #873.

Prudential Financial first reported a position in PRAX in Q3 2023 and has held it in 4 quarters since. The position peaked at $9.83M in Q1 2026. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Prudential Financial held 19,541 shares of Praxis Precision Medicines worth $6.54M as of Q2 2026.
  • Prudential Financial sold 10,969 Praxis Precision Medicines shares in Q2 2026, an estimated $3.47M.
  • Praxis Precision Medicines made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #873 holding.
  • Prudential Financial first reported a position in Praxis Precision Medicines in Q3 2023 and has held it in 4 quarters since.
  • Prudential Financial's Praxis Precision Medicines position peaked at $9.83M in Q1 2026.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.